Navigation Links
Quintessence Biosciences names new president

Madison, Wis. - Laura Strong, who has served as vice president of Quintessence Biosciences since the year 2000, has been appointed president and chief operating officer of the Madison-based biopharmaceutical company.

The appointment was made by the company's board of directors and announced at the company's annual shareholder's meeting.

Full article >>>
'"/>

Source:wistechnology.com By WTN News 02/08/07


Page: 1

Related biology technology :

1. Quintessence Biosciences advances cancer drug
2. Quintessence cancer treatment chosen for clinical studies
3. Quintessence division to develop drug tests with NIH grant
4. Quintessence Biosciences forms cancer therapeutic advisory board
5. Quintessence Secures Financing
6. Perscitus Biosciences secures $250K Commerce loan
7. Caden Biosciences may signal critical mass
8. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
9. WARF signs licensing pact with BD Biosciences
10. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
11. State awards QRG Biosciences development grant
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... for financial services, but it also plays a fundamental part ...
Breaking Biology News(10 mins):